ÃÑ 1365ÆäÀÌÁö
909ÆäÀÌÁö º»¹®½ÃÀÛ
Ç¥
ÁØ
- À½¼º´ëÁ¶¹°Áú : DMSO
±â
- ½Ã Çè ¹° Áú : arsanilic acid, danofloxacin, mercury
¼ú
- °ø ½Ã ¹è Áö : neural medium, DMEM/F12K, N2 serum-free supplement (x100),
È°
B27 serum-free supplement (x50)
¿ë
- ½Ã Çè ±â ±â : ¼¼Æ÷¿µ»óºÐ¼®±â(Cell imaging High Content Screening, Cellomics),
Çü±¤ºÐ¼®±â(fluorescence microplate reader)
2) ¹æ ¹ý
?½Å°æºÐȹèÁö Á¦Á¶
- DMEM/F12K1+N2 serum-free supplement+B27 serum-free supplement
?GelatinÀÌ ÄÚÆÃµÈ 12 well Ç÷¹ÀÌÆ®¿¡ ¸¶¿ì½º ¹è¾ÆÁٱ⼼Æ÷ (NVRQS-ES 11F)
5x102cells/well¸¦ ºÐÁÖÇÏ¿© 24½Ã°£µ¿¾È 37¡É, 5% CO2 Á¶°Ç¿¡¼ÇϷ絿¾È ¹è¾ç
?½Å°æºÐȹèÁö¿Í ÇÔ²² ´Ü°èº°·Î Èñ¼®ÇÑ ½ÃÇè¹°ÁúÀ» °¢ ¿ë·®º°·Î well¿¡ 1§¢¾¿ Åõ
¿©ÇÏ°í 37¡É, 5% CO2 Á¶°Ç¿¡¼¹ÝÀÀ
?½Å°æ¼¼Æ÷ ºÐÈ Áֱ⺰ È®ÀÎ : ½Å°æºÐȹèÁö·Î ±³Ã¼ ÈÄ 0, 2, 4, 6, 8, 10, 12, 14, 16
ÀÏ¿¡ ºÐÈÁöÇ¥ÀÇ ´Ü¹éÁú(Oct4, GABA-R, GFAP, Nestin, TUJ-1, MAP2) ¹ßÇöÀ»
È®ÀÎ
- Oct4, GABA-R, GFAP, Nestin, TUJ-1, MAP2 antibody solution 500§¡¸¦ well
¿¡ ³Ö°í, ½Ç¿Â¿¡¼ 1½Ã°£ µ¿¾È ¹ÝÀÀ
- Secondary antibody¿Í Hoechst dye 500§¡¸¦ °¢ well¿¡ ³ÖÀº ´ÙÀ½ ½Ç¿Â¿¡¼ 45
ºÐ µ¿¾È ¹ÝÀÀ
?¼¼Æ÷¿µ»óºÐ¼®±â(Cell imaging High Content Screening, Cellomics)·Î Çü±¤µµ ÃøÁ¤
?½Å°æºÐÈ µ¶¼ºÆò°¡ ±âÁØ
- Oct4ÀÇ Çü±¤µµ°¡ ´ëÁ¶±º ¼¼Æ÷¿¡ ºñÇØ Åë°èÇÐÀûÀ¸·Î À¯ÀǼºÀÖ°Ô °¨¼ÒÇÏ°í
GABA-R, GFAP, Nestin, TUJ-1, MAP2 Çü±¤µµ°¡ ´ëÁ¶±º ¼¼Æ÷¿¡ ºñÇØ Åë°èÇÐ
ÀûÀ¸·Î À¯ÀǼº ÀÖ°Ô Áõ°¡ÇÏ¸é ½Å°æºÐÈ¿¡ ¿µÇâÀ» ÁÖ´Â °ÍÀ¸·Î Æò°¡ÇÑ´Ù.
?¾Æ¼¼Æ¿Äݸ° ¿¡½ºÅ׶óÁ¦ ÃøÁ¤¿¡ ÀÇÇÑ ½Å°æµ¶¼º Æò°¡
- ½ÃÇè¹°Áú¿¡ Áö¼ÓÀûÀ¸·Î ³ëÃâµÈ ½Å°æºÐȼ¼Æ÷¸¦ ¼ö°ÅÇÏ¿© ¾Æ¼¼Æ¿Äݸ° ¿¡½ºÅ׶ó
Á¦ È°¼ºÀ» ÃøÁ¤ÇÏ¿© ´ëÁ¶±º ¼¼Æ÷¿¡ ºñÇØ Åë°èÇÐÀûÀ¸·Î À¯ÀǼº ÀÖ°Ô °¨¼ÒÇϸé
½Å°æ ±â´É¿¡ ¿µÇâÀ» ÁÖ´Â °ÍÀ¸·Î Æò°¡ÇÑ´Ù.
6. »öÀοë¾î ¸¶¿ì½º¹è¾ÆÁٱ⼼Æ÷, ½Å°æÀü±¸¼¼Æ÷, ½Å°æ¼¼Æ÷, ½Å°æµ¶¼º
15
ÁØ
- À½¼º´ëÁ¶¹°Áú : DMSO
±â
- ½Ã Çè ¹° Áú : arsanilic acid, danofloxacin, mercury
¼ú
- °ø ½Ã ¹è Áö : neural medium, DMEM/F12K, N2 serum-free supplement (x100),
È°
B27 serum-free supplement (x50)
¿ë
- ½Ã Çè ±â ±â : ¼¼Æ÷¿µ»óºÐ¼®±â(Cell imaging High Content Screening, Cellomics),
Çü±¤ºÐ¼®±â(fluorescence microplate reader)
2) ¹æ ¹ý
?½Å°æºÐȹèÁö Á¦Á¶
- DMEM/F12K1+N2 serum-free supplement+B27 serum-free supplement
?GelatinÀÌ ÄÚÆÃµÈ 12 well Ç÷¹ÀÌÆ®¿¡ ¸¶¿ì½º ¹è¾ÆÁٱ⼼Æ÷ (NVRQS-ES 11F)
5x102cells/well¸¦ ºÐÁÖÇÏ¿© 24½Ã°£µ¿¾È 37¡É, 5% CO2 Á¶°Ç¿¡¼ÇϷ絿¾È ¹è¾ç
?½Å°æºÐȹèÁö¿Í ÇÔ²² ´Ü°èº°·Î Èñ¼®ÇÑ ½ÃÇè¹°ÁúÀ» °¢ ¿ë·®º°·Î well¿¡ 1§¢¾¿ Åõ
¿©ÇÏ°í 37¡É, 5% CO2 Á¶°Ç¿¡¼¹ÝÀÀ
?½Å°æ¼¼Æ÷ ºÐÈ Áֱ⺰ È®ÀÎ : ½Å°æºÐȹèÁö·Î ±³Ã¼ ÈÄ 0, 2, 4, 6, 8, 10, 12, 14, 16
ÀÏ¿¡ ºÐÈÁöÇ¥ÀÇ ´Ü¹éÁú(Oct4, GABA-R, GFAP, Nestin, TUJ-1, MAP2) ¹ßÇöÀ»
È®ÀÎ
- Oct4, GABA-R, GFAP, Nestin, TUJ-1, MAP2 antibody solution 500§¡¸¦ well
¿¡ ³Ö°í, ½Ç¿Â¿¡¼ 1½Ã°£ µ¿¾È ¹ÝÀÀ
- Secondary antibody¿Í Hoechst dye 500§¡¸¦ °¢ well¿¡ ³ÖÀº ´ÙÀ½ ½Ç¿Â¿¡¼ 45
ºÐ µ¿¾È ¹ÝÀÀ
?¼¼Æ÷¿µ»óºÐ¼®±â(Cell imaging High Content Screening, Cellomics)·Î Çü±¤µµ ÃøÁ¤
?½Å°æºÐÈ µ¶¼ºÆò°¡ ±âÁØ
- Oct4ÀÇ Çü±¤µµ°¡ ´ëÁ¶±º ¼¼Æ÷¿¡ ºñÇØ Åë°èÇÐÀûÀ¸·Î À¯ÀǼºÀÖ°Ô °¨¼ÒÇÏ°í
GABA-R, GFAP, Nestin, TUJ-1, MAP2 Çü±¤µµ°¡ ´ëÁ¶±º ¼¼Æ÷¿¡ ºñÇØ Åë°èÇÐ
ÀûÀ¸·Î À¯ÀǼº ÀÖ°Ô Áõ°¡ÇÏ¸é ½Å°æºÐÈ¿¡ ¿µÇâÀ» ÁÖ´Â °ÍÀ¸·Î Æò°¡ÇÑ´Ù.
?¾Æ¼¼Æ¿Äݸ° ¿¡½ºÅ׶óÁ¦ ÃøÁ¤¿¡ ÀÇÇÑ ½Å°æµ¶¼º Æò°¡
- ½ÃÇè¹°Áú¿¡ Áö¼ÓÀûÀ¸·Î ³ëÃâµÈ ½Å°æºÐȼ¼Æ÷¸¦ ¼ö°ÅÇÏ¿© ¾Æ¼¼Æ¿Äݸ° ¿¡½ºÅ׶ó
Á¦ È°¼ºÀ» ÃøÁ¤ÇÏ¿© ´ëÁ¶±º ¼¼Æ÷¿¡ ºñÇØ Åë°èÇÐÀûÀ¸·Î À¯ÀǼº ÀÖ°Ô °¨¼ÒÇϸé
½Å°æ ±â´É¿¡ ¿µÇâÀ» ÁÖ´Â °ÍÀ¸·Î Æò°¡ÇÑ´Ù.
6. »öÀοë¾î ¸¶¿ì½º¹è¾ÆÁٱ⼼Æ÷, ½Å°æÀü±¸¼¼Æ÷, ½Å°æ¼¼Æ÷, ½Å°æµ¶¼º
15
909ÆäÀÌÁö º»¹®³¡
¸Þ´º
ÇöÀç Æ÷Ä¿½ºÀÇ ¾Æ·¡³»¿ëµéÀº µ¿ÀÏÇÑ ÄÁÅÙÃ÷¸¦ °¡Áö°í ÆäÀÌÁö³Ñ±è È¿°ú¹× ½Ã°¢Àû È¿°ú¸¦ Á¦°øÇÏ´Â ÆäÀÌÁöÀ̹ǷΠ½ºÅ©¸°¸®´õ »ç¿ëÀÚ´Â ¿©±â±îÁö¸¸ ³¶µ¶ÇϽðí À§ÀÇ ÆäÀÌÁöÀ̵¿ ¸µÅ©¸¦ »ç¿ëÇÏ¿© ´ÙÀ½ÆäÀÌÁö·Î À̵¿ÇϽñ⠹ٶø´Ï´Ù.